World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
15420
World Ranking
2845
National Ranking
1346

Douglas B. Kuhns publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Douglas B. Kuhns sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 148 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Douglas B. Kuhns D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas B. Kuhns sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Douglas B. Kuhns is affiliated with the National Institutes of Health in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Infectious Diseases, Molecular Biology, Genetics, and Rheumatology.

The main topics of Kuhns's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Immunodeficiency and Autoimmune Disorders, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Cell Adhesion Molecules Research, T-cell and B-cell Immunology, and Fungal Infections and Studies.

Frequent publication venues for Kuhns's research include:

  • JCI Insight
  • Blood Cells Molecules and Diseases
  • Journal of Clinical Immunology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Nature Medicine

Some of the recent papers associated with Kuhns cover a range of immunological and clinical topics:

  • "An immune-based biomarker signature is associated with mortality in COVID-19 patients," 2020, JCI Insight
  • "Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19," 2022, Nature Medicine
  • "Lentiviral gene therapy for X-linked chronic granulomatous disease," 2020, Nature Medicine
  • "Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19," 2021, Cell
  • "HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease," 2020, Science

Kuhns frequently collaborates with other researchers including Danielle Fink, Steven M. Holland, Michail S. Lionakis, Luigi D. Notarangelo, and Ottavia M. Delmonte. The number of co-authored works with these colleagues ranges from 12 to 24 publications.

Best Publications

  • STAT3 Mutations in the Hyper-IgE Syndrome

    Steven M. Holland;Frank R. DeLeo;Houda Z. Elloumi;Amy P. Hsu

  • Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

    Amy P. Hsu;Elizabeth P. Sampaio;Javed Khan;Katherine R. Calvo

  • Residual NADPH oxidase and survival in chronic granulomatous disease.

    Douglas B. Kuhns;W. Gregory Alvord;Theo Heller;Jordan J. Feld

  • Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor.

    Ji-Liang Gao;D. B. Kuhns;H. L. Tiffany;D. Mcdermott

  • Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia

    Miriam Y. Kim;Kyung Rok Yu;Saad S. Kenderian;Marco Ruella

  • Common Severe Infections in Chronic Granulomatous Disease

    Beatriz E. Marciano;Christine Spalding;Alan Fitzgerald;Daphne Mann

  • Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.

    Steven M. Holland;Eli M. Eisenstein;Douglas B. Kuhns;Maria L. Turner

  • A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

    Qing Zhou;Geun-Shik Lee;Geun-Shik Lee;Jillian Brady;Shrimati Datta

  • Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia

    Donald C. Vinh;Smita Y. Patel;Gulbu Uzel;Victoria L. Anderson

  • Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

    Unknown

  • An immune-based biomarker signature is associated with mortality in COVID-19 patients.

    Michael S. Abers;Ottavia M. Delmonte;Emily E. Ricotta;Jonathan Fintzi

  • Distinct Mutations in IRAK-4 Confer Hyporesponsiveness to Lipopolysaccharide and Interleukin-1 in a Patient with Recurrent Bacterial Infections

    Andrei E. Medvedev;Arnd Lentschat;Arnd Lentschat;Douglas B. Kuhns;Jorge C.G. Blanco

  • CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.

    Suk See De Ravin;Linhong Li;Xiaolin Wu;Uimook Choi

  • Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency

    Suk See De Ravin;Xiaolin Wu;Susan Moir;Lela Kardava

  • Hematologically important mutations: X-linked chronic granulomatous disease (third update).

    Dirk Roos;Douglas B. Kuhns;Anne Maddalena;Joachim Roesler

  • Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils

    Elizabeth M. Kang;Uimook Choi;Narda Theobald;Gilda Linton

  • Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis

    Elizabeth P. Sampaio;Elizabeth P. Sampaio;Amy P. Hsu;Joseph Pechacek;Hannelore I. Bax;Hannelore I. Bax

  • Lentiviral gene therapy for X-linked chronic granulomatous disease.

    Donald B. Kohn;Claire Booth;Elizabeth M. Kang;Sung-Yun Pai

  • Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

    Andrew P. Demidowich;Alexandra F. Freeman;Douglas B. Kuhns;Ivona Aksentijevich

  • Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.

    Can Liu;Can Liu;Andrew J. Martins;William W. Lau;Nicholas Rachmaninoff;Nicholas Rachmaninoff

  • Chromothriptic Cure of WHIM Syndrome

    David H. McDermott;Ji-Liang Gao;Qian Liu;Marie Siwicki

  • Increased Circulating Cytokines, Cytokine Antagonists, And E-Selectin After Intravenous Administration Of Endotoxin In Humans

    D B Kuhns;W G Alvord;J I Gallin

Frequent Co-Authors

Harry L. Malech
Harry L. Malech National Institutes of Health
John I. Gallin
John I. Gallin National Institutes of Health
Steven M. Holland
Steven M. Holland National Institute of Allergy and Infectious Diseases
Steven M. Holland
Steven M. Holland University of Georgia
Amy P. Hsu
Amy P. Hsu National Institutes of Health
Alexandra F. Freeman
Alexandra F. Freeman National Institute of Allergy and Infectious Diseases
Gulbu Uzel
Gulbu Uzel National Institute of Allergy and Infectious Diseases
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health
Theo Heller
Theo Heller National Institutes of Health
Kenneth N. Olivier
Kenneth N. Olivier National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring healthcare-related online degrees can open diverse career pathways. Many students transition into nursing as a complementary field, where understanding immune responses is crucial. Programs like accelerated nurse practitioner programs offer a fast track for those already holding a degree, combining advanced clinical training with immunology principles.

Beginners or career changers may consider online BSN programs for non nurses, which provide foundational nursing education with flexible schedules. These programs can be a stepping stone towards more specialized roles in immunology-related healthcare fields.

For quicker entry into nursing, accelerated nursing programs offer streamlined curricula designed to prepare students rapidly for clinical practice, often incorporating immunology coursework relevant to patient care.

Alternatively, fastest and easiest LPN programs provide one of the quickest routes to licensure, enabling graduates to support immunology-related health services in various medical settings. Considering these educational paths can help expand career options in health science fields linked to immunology.

Best Scientists Citing Douglas B. Kuhns

Trending Scientists

Recently Published Articles